Search research articles
Contact Us
Filters
Showing results (411-420 of 494) with videos related to
Page
of 50
Sort By:
Journal of Medicinal Chemistry
|
September 2, 2021
Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer
Weiguo Xiang, Lijie Zhao, Xin Han, et al.
Nature Chemical Biology
|
July 1, 2008
A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo
Scott A Yuzwa, Matthew S Macauley, Julia E Heinonen, et al.
Molecular and Cellular Biology
|
April 30, 2014
The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling
Bo Cen, Ying Xiong, Jin H Song, et al.
Molecular Neurodegeneration
|
October 27, 2014
Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau/APP mutant mice
Scott A Yuzwa, Xiaoyang Shan, Bryan A Jones, et al.
Journal of Virology
|
September 29, 2006
Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine
Bruce A Mungall, Deborah Middleton, Gary Crameri, et al.
Journal of Medicinal Chemistry
|
March 25, 2017
Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression
Bing Zhou, Jiantao Hu, Fuming Xu, et al.
Molecular Cancer Therapeutics
|
March 5, 2011
Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment
Jianfeng Lu, Donna McEachern, Haiying Sun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 6, 2002
Demonstration of feasibility of in vivo gene therapy for Gaucher disease using a chemically induced mouse model
John Marshall, Kerry Anne McEachern, Julie A Cavanagh Kyros, et al.
Clinical Neurology and Neurosurgery
|
February 7, 2018
Streamlined triage and transfer protocols improve door-to-puncture time for endovascular thrombectomy in acute ischemic stroke
Akash P Kansagra, Adam N Wallace, David R Curfman, et al.
Movement Disorders Clinical Practice
|
June 18, 2025
Developing an Outpatient Transdisciplinary Functional Movement Disorder Program: 1-Year Experience
Gabriela S Gilmour, Kayla Fritz, Joanne Stephen, et al.
Page
of 50
Search research articles
Search
Showing results (411-420 of 494) with videos related to
Sort By:
Page
of 50
Journal of Medicinal Chemistry
|
September 2, 2021
Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer
Weiguo Xiang, Lijie Zhao, Xin Han, et al.
Nature Chemical Biology
|
July 1, 2008
A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo
Scott A Yuzwa, Matthew S Macauley, Julia E Heinonen, et al.
Molecular and Cellular Biology
|
April 30, 2014
The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling
Bo Cen, Ying Xiong, Jin H Song, et al.
Molecular Neurodegeneration
|
October 27, 2014
Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau/APP mutant mice
Scott A Yuzwa, Xiaoyang Shan, Bryan A Jones, et al.
Journal of Virology
|
September 29, 2006
Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine
Bruce A Mungall, Deborah Middleton, Gary Crameri, et al.
Journal of Medicinal Chemistry
|
March 25, 2017
Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression
Bing Zhou, Jiantao Hu, Fuming Xu, et al.
Molecular Cancer Therapeutics
|
March 5, 2011
Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment
Jianfeng Lu, Donna McEachern, Haiying Sun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 6, 2002
Demonstration of feasibility of in vivo gene therapy for Gaucher disease using a chemically induced mouse model
John Marshall, Kerry Anne McEachern, Julie A Cavanagh Kyros, et al.
Clinical Neurology and Neurosurgery
|
February 7, 2018
Streamlined triage and transfer protocols improve door-to-puncture time for endovascular thrombectomy in acute ischemic stroke
Akash P Kansagra, Adam N Wallace, David R Curfman, et al.
Movement Disorders Clinical Practice
|
June 18, 2025
Developing an Outpatient Transdisciplinary Functional Movement Disorder Program: 1-Year Experience
Gabriela S Gilmour, Kayla Fritz, Joanne Stephen, et al.
Page
of 50